| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Early Phase 1 | |||
| NCT06541444 | Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia | Relapsed/Refractory Acute Myeloid Leukemia | Recruiting |
| NCT07561437 | NK521 in the Treatment of Malignant Ascites Associated With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting |
| NCT06097962 | Safety and Efficacy of NK510 to Treat NSCLC | NSCLC | Recruiting |
| NCT07166263 | Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer | Gastric Cancer (GC) | Not Yet Recruiting |
| NCT07657416 | NK521 in the Treatment of Advanced Solid Tumors | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |
| Not specified | |||
| NCT07083349 | NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus | Refractory Systemic Lupus Erythematosus | Not Yet Recruiting |